1st Quarter - Report

2008 1st Quarter (Jan 1 - Mar 31) Foreign Entity
Income
$20,000
Expenses
—
Official Senate LDA Document

Lobbying Activities

Homeland Security; BioShield; Biomedical Countermeasures; Biodefense Research and Development Authority.
Foreign Issues

All Issues

Bodies Contacted
HOUSE OF REPRESENTATIVES Health & Human Services, Dept of (HHS) SENATE

Foreign Entities

AVECIA BIOTECHNOLOGY
Country: United Kingdom Contribution: $1,333
BAVARIAN NORDIC A/S
Country: Denmark Contribution: $1,333
CANGENE CORPORATION
Country: Canada Contribution: $1,333

Affiliated Organizations

AVECIA BIOTECHNOLOGY
Billingham TS23 1YN, GB
BAVARIAN NORDIC, INC. US
Washington, DC, US
CANGENE CORPORATION
Winnipeg, MB R3T 5Y3, MB, CA
CENTER FOR BIOSECURITY OF UPMC........
Baltimore, MD, US
DOR BIOPHARMA
Ewing, NJ, US
DYNPORT VACCINES CO. LLC
Frederick, MD, US
ELUSYS THERAPEUTICS, INC.
Pine Brook, NJ, US
EMERGENT BIOSOLUTIONS
Gaithersburg, MD, US
HEMATECH, INC.
Sioux Falls, SD, US
HUMAN GENOME SCIENCES, INC.
Rockville, MD, US
IOMAI CORPORATION
Gaithersburg, MD, US
NANOVIRICIDES, INC.
West Haven, CT, US
PFIZER INC.
New York, NY, US
PHARMATHENE
Annapolis, MD, US
SIGA TECHNOLOGIES
New York, NY, US